Studier

Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskus ® or Pressuriced Metered-Dose Inhaler in Children with Asthma.

*EXCEL: Regular maintenance therapy with salmeterol/fluticasone propionate combination (SFC) reduces exacerbations more effectively than with formoterol/budesonide combination (FBC)

The CONCEPT Trial: A 1-Year, Multicenter, Randomized, Doble-blind, Doble-Dummy Comparison of Stable Dosing Regimen of Salmeterol/Fluticasone Propionate with an Adjustable Maintenance Dosing Regiment of Formoterol/Budesonide in Adults with Persistent Asthma

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma controL study

Evaluation of Different Inhaled Combination Therapies (EDICT):a randomised, double-blind comparison of SeretideTM (50/250 µg bd DiskusTM) vs. formoterol (12 µg bd) and budesonide (800 µg bd) given concurrently (both via TurbuhalerTM) in patients with moderate-to-severe asthma.

Clinical management of asthma in 1999: the Asthma Insight and Reality in Europe (AIRE) study.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial.

Combined Salmeterol 50 µg and Fluticasone propionate 250 µg in the Diskus Device for the Treatment of Asthma.